Quarterly
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||
current assets: | |||||||||||||
cash and cash equivalents | 11,495,000 | 14,502,000 | 18,085,000 | 15,448,000 | 11,057,000 | 11,568,000 | 23,216,000 | 34,382,000 | 59,107,000 | 50,366,000 | 23,982,000 | 13,219,000 | 28,508,534 |
short-term investments | 4,490,000 | 10,429,000 | 22,242,000 | 20,717,000 | 17,650,000 | 11,924,000 | 11,916,000 | 30,345,000 | 58,181,000 | 39,924,000 | 37,404,750 | ||
prepaid expenses and other current assets | 457,000 | 1,714,000 | 2,403,000 | 2,760,000 | 2,695,000 | 5,147,000 | 4,748,000 | 3,836,000 | 2,874,000 | 2,659,000 | 3,011,000 | 2,288,000 | 1,185,844 |
total current assets | 11,952,000 | 16,216,000 | 24,978,000 | 33,646,000 | 41,887,000 | 42,480,000 | 49,349,000 | 53,911,000 | 76,735,000 | 83,370,000 | 85,174,000 | 55,431,000 | 67,099,128 |
operating lease right-of-use assets | 246,000 | 280,000 | 364,000 | 473,000 | 592,000 | 694,000 | 796,000 | 922,000 | 1,191,000 | 1,645,000 | |||
property and equipment | 201,000 | 233,000 | 262,000 | 293,000 | 329,000 | 361,000 | 315,000 | 313,000 | 391,000 | 237,000 | 239,000 | 93,000 | 63,515 |
total assets | 12,399,000 | 16,729,000 | 25,604,000 | 34,457,000 | 42,861,000 | 43,597,000 | 50,530,000 | 55,225,000 | 78,421,000 | 85,405,000 | 85,428,000 | 55,539,000 | 67,162,643 |
liabilities and stockholders' equity | |||||||||||||
current liabilities: | |||||||||||||
accounts payable | 4,812,000 | 3,058,000 | 2,676,000 | 3,666,000 | 4,486,000 | 2,778,000 | 4,707,000 | 3,635,000 | 3,977,000 | 1,225,000 | 2,766,000 | 1,873,000 | 1,119,150 |
accrued expenses | 2,272,000 | 2,798,000 | 3,483,000 | 5,049,000 | 6,903,000 | 5,646,000 | 6,697,000 | 8,304,000 | 7,239,000 | 5,886,000 | 2,813,000 | 2,010,000 | 908,827 |
current portion of operating lease liabilities | 150,000 | 146,000 | 197,000 | 274,000 | 350,000 | 424,000 | 440,000 | 428,000 | 408,000 | 376,000 | |||
total current liabilities | 7,234,000 | 6,002,000 | 6,356,000 | 11,057,000 | 20,169,000 | 22,208,000 | 27,573,000 | 28,199,000 | 32,038,000 | 8,915,000 | 7,245,000 | 3,883,000 | 2,027,977 |
long-term operating lease liabilities | 109,000 | 149,000 | 187,000 | 223,000 | 259,000 | 295,000 | 384,000 | 498,000 | 824,000 | 1,235,000 | |||
total liabilities | 7,343,000 | 6,151,000 | 6,543,000 | 11,280,000 | 20,428,000 | 22,503,000 | 27,957,000 | 31,117,000 | 46,479,000 | 18,900,000 | 15,574,000 | 13,691,000 | 2,227,507 |
commitments and contingencies | |||||||||||||
stockholders' equity: | |||||||||||||
common stock | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 2,000 | 2,000 | 1,000 | 789 |
additional paid-in capital | 212,868,000 | 212,305,000 | 212,084,000 | 211,190,000 | 210,185,000 | 209,142,000 | 208,170,000 | 207,045,000 | 204,268,000 | 176,618,000 | 141,074,000 | 82,938,000 | 80,441,417 |
accumulated other comprehensive income | 385,000 | 731,000 | 781,000 | -3,000 | 251,000 | 423,000 | 140,000 | 458,000 | 76,000 | -297,000 | 21,000 | ||
accumulated deficit | -208,200,000 | -202,461,000 | -193,807,000 | -188,013,000 | -188,006,000 | -188,474,000 | -185,740,000 | -183,398,000 | -172,405,000 | -109,977,000 | -70,925,000 | -41,112,000 | -15,512,349 |
total stockholders' equity | 5,056,000 | 10,578,000 | 19,061,000 | 23,177,000 | 22,433,000 | 21,094,000 | 22,573,000 | 24,108,000 | 31,942,000 | 66,505,000 | 69,854,000 | 41,848,000 | 64,935,136 |
total liabilities and stockholders' equity | 12,399,000 | 16,729,000 | 25,604,000 | 34,457,000 | 42,861,000 | 43,597,000 | 50,530,000 | 55,225,000 | 78,421,000 | 85,405,000 | 85,428,000 | 55,539,000 | 67,162,643 |
accounts receivable | 5,009,000 | 5,893,000 | 5,048,000 | 3,735,000 | 3,769,000 | 2,838,000 | |||||||
other assets | 45,000 | 53,000 | 62,000 | 70,000 | 79,000 | 104,000 | 153,000 | 15,000 | 15,000 | ||||
current portion of deferred revenue | 2,068,000 | 8,430,000 | 13,360,000 | 15,729,000 | 15,832,000 | 14,700,000 | |||||||
current portion of notes payable | |||||||||||||
long-term notes payable | 3,239,000 | 8,750,000 | 8,275,000 | 9,681,000 | |||||||||
long-term deferred revenue | 2,420,000 | 10,378,000 | |||||||||||
current portion of long-term notes payable | 5,714,000 | 1,428,000 | 1,666,000 | ||||||||||
other non-current liabilities | 54,000 | 127,000 | 199,530 | ||||||||||
accumulated other comprehensive loss | -138,000 | ||||||||||||
long-term convertible promissory notes | |||||||||||||
long-term convertible promissory notes, related party | |||||||||||||
biocon anti-dilution right | |||||||||||||
stockholders' equity | |||||||||||||
accumulated other comprehensive gain | 5,279 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.